Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 7739862

Electromagnetic ossicular augmentation device.

J M Kartush·M Tos
View original source ↗Export metadata ↓

Abstract

Conventional hearing aids have a number of limitations inherent to amplifying sound in the narrow confines of the external auditory canal. Disadvantages include acoustic feedback, poor fidelity, and the stigmata of aging. Since 1986, Michigan Ear Institute and Smith and Nephew Richards Company have been investigating the feasibility of a new device that converts sound to an electromagnetic field. The efficacy and safety of electromagnetic-induced hearing was sufficient enough to have the Federal Food and Drug Administration approve a pilot study of ten patients with a sensorineural hearing loss in whom a target magnet is implanted beneath the tympanic membrane. A status report of this study and a review of our preceeding investigations are presented in this article.

Explore related subjects

Audiometry, Pure-ToneEar OssiclesEquipment DesignHearing AidsHearing Loss, High-FrequencyHumansMagneticsProstheses and ImplantsSpeech Discrimination TestsSpeech Reception Threshold TestJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J M Kartush, M Tos. 1995. Electromagnetic ossicular augmentation device.. https://pubmed.ncbi.nlm.nih.gov/7739862/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1997

Fate of middle ear implants.

During the period 1981 through 1993, 613 cases out of a total of 4340 ear operations performed, needed ossicular chain reconstruction. This excludes stapedectomy operations. Out of 613 cases, 371 were cholesteatomatous and the rest were of safe chronic otitis media. Various graft materials used in ossicular reconstruction consisted of autologous ossicles or tragal cartilage, homologous preserved ossicles, cortical bone, human dentine, cadaveric styloid process and gold prosthesis. Results of the study show the extrusion rate of 1.54% with autologous ossicles, 1.43% with homologous ossicles, 1.19% with tragal cartilage, 3.61% with human cadaveric costal cartilage, 5.45% with cadaveric styloid process, 7.14% with dentine and 8.70% with gold prosthesis. These results are largely comparable with other studies. Natural graft materials like autologous and homologous ossicles have been found to have better take-up and long-term acceptance.

Audiometry, Pure-Tone↗
PubMed1997

Management of 1000 vestibular schwannomas (acoustic neuromas): hearing function in 1000 tumor resections.

OBJECTIVE: The realistic chances of hearing preservation and the comparability of international results on hearing preservation in complete microsurgical vestibular schwannoma resections were the focus of this study in a large patient population treated by uniform principles. METHODS: One thousand vestibular schwannomas were operated on at Nordstadt Neurosurgical Department, from 1978 to 1993, by the senior surgeon (MS). There were 1000 tumors in 962 patients, i.e., 880 patients with unilateral tumors and 82 patients operated on for bilateral tumors in neurofibromatosis-2 (120 cases). Preservation of the cochlear nerve was attempted whenever possible. The audiometric data were analyzed by the Nordstadt classification system and graded in steps of 30 dB by audiometry and in steps of 10 to 30% by speech discrimination; for comparability, the data were also evaluated by the criteria of Gardner, Shelton, and House, and they were assessed in relation to the Hannover tumor extension grading system. RESULTS: Anatomic cochlear nerve preservation was achieved in 682 of 1000 cases (68%), as well as in some preoperatively deaf patients, a very few of whom regained some hearing. Of a total of 732 cases with some preoperative hearing, anatomic cochlear nerve preservation was achieved in 580 cases (79%) and functional cochlear nerve preservation in 289 (39.5%); analysis over time revealed an actual preservation rate of 47% in the most recent 200 cases. Specific factors, such as gender, tumor extension, preoperative hearing quality, and symptom duration, were investigated for their predictive value for hearing preservation. Male gender, small to medium tumor size (mainly extending within the cerebellopontine cistern; Classes T2 and T3), good to moderate hearing (up to 40-dB loss), and short duration of hypoacusis (< 1.5 yr) or of vestibular disturbances (< 0.7 yr) were advantageous factors, with chances of hearing preservation between 47 and 88%. CONCLUSION: Functional cochlear nerve preservation in complete microsurgical resection should belong to the contemporary standard of treatment goals.

Audiometry, Pure-Tone↗